48 results
Page 2 of 3
8-K
EX-99.1
lc8a57rhin6hs
31 Jul 20
AbbVie Reports Second-Quarter 2020 Financial Results
8:41am
S-8
EX-4.3
pa6a6
19 Jun 20
Registration of securities for employees
5:01pm
8-K
EX-4.15
j1mc43
14 May 20
AbbVie Announces Final Results of Exchange Offers for Allergan Notes
4:16pm
8-K
EX-4.2
fwmt7onwtvn ns6
26 Sep 19
Entry into a Material Definitive Agreement
4:06pm
424B5
el69kb6z07w ax
19 Sep 19
Prospectus supplement for primary offering
5:18pm
424B3
w67rzx4
16 Sep 19
Prospectus supplement
6:14am
8-K
EX-10.1
oxp85k
30 Aug 19
Entry into a Material Definitive Agreement
4:19pm
8-K
EX-10.2
37c 7aqzq6
16 Jul 19
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-2.3
n7k89h703d13 15j
25 Jun 19
This Announcement Is Being Made Pursuant to Rule 2.5 of the Irish Takeover Rules
5:26pm
425
EX-4.1
09og32ero5xgc0ifmv
6 Mar 15
Business combination disclosure
12:00am
8-K
EX-2.1
qjm54mf6n spohr3x
6 Mar 15
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
y1ggff9
6 Mar 15
Business combination disclosure
12:00am